Evidence map›Paper›PMID 33180964›Full record

ArticleClinical cardiology2021

Re: Is there a difference in the effect between the angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker on the COVID-19?

Xiao Liu, Chuyan Long, Qinmei Xiong, Chen Chen, Jianyong Ma, Yuhao Su, Kui Hong

Abstract readLetterComment
In one paragraph

Article in Clinical cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Xiao LiuDepartment of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Jiangxi, China.ORCID 0000-0002-5570-289X
Chuyan LongDepartment of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Jiangxi, China.
Qinmei XiongDepartment of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Jiangxi, China.
Chen ChenDepartment of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Jiangxi, China.
Jianyong MaDepartment of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Jiangxi, China.
Yuhao SuDepartment of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Jiangxi, China.
Kui HongDepartment of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Jiangxi, China.ORCID 0000-0002-0875-0557

Funding

National Natural Science Foundation of China 81530013National Natural Science Foundation of China 81600243Scientific and Technical Innovation Group of Jiangxi Province 20181BCB24012
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiotensin Receptor AntagonistsCOVID-19Angiotensin-Converting Enzyme InhibitorsAngiotensinsHumansSARS-CoV-2Angiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsAngiotensins

Identifiers

PMID33180964
PMCPMC7803360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.